Ceryvyn Therapeutics Ltd
OPT
Rang in aandelen
#31857
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Aandeelprijs
$0.00846342
Laatst gesynchroniseerd: 2026-07-27
Marktkapitalisatie
$11.27M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-99.75%
Land
AU
Handel Ceryvyn Therapeutics Ltd (OPT)
Categorie
Healthcare
Aandelsplitsingen voor Ceryvyn Therapeutics Ltd (OPT)
Het aandeel Ceryvyn Therapeutics Ltd (symbool: OPT) heeft in totaal 2 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 16, 2020.
Eén aandeel OPT dat vóór Sep 13, 2016 werd gekocht, staat nu gelijk aan 0.638125 aandelen OPT.
De meest recente splitsing vond plaats op Oct 16, 2020.
Eén aandeel OPT dat vóór Sep 13, 2016 werd gekocht, staat nu gelijk aan 0.638125 aandelen OPT.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2020-10-16 | 5:8 | x0.625 | x0.638125 |
| 2016-09-13 | 1021:1000 | x1.021 | x1.021 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
